Arax Advisory Partners’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2K | Sell |
867
-2
| -0.2% | -$47 | ﹤0.01% | 1654 |
|
|
2025
Q1 | $13.2K | Buy |
869
+667
| +330% | +$10.1K | ﹤0.01% | 1473 |
|
|
2024
Q4 | $3.71K | Sell |
202
-8
| -4% | -$147 | ﹤0.01% | 1842 |
|
|
2024
Q3 | $2.33K | Hold |
210
| – | – | ﹤0.01% | 2007 |
|
|
2024
Q2 | $1.95K | Buy |
210
+8
| +4% | +$74 | ﹤0.01% | 1978 |
|
|
2024
Q1 | $6.62K | Hold |
202
| – | – | ﹤0.01% | 853 |
|
|
2023
Q4 | $5.41K | Hold |
202
| – | – | ﹤0.01% | 876 |
|
|
2023
Q3 | $12.2K | Buy |
202
+139
| +221% | +$8.41K | ﹤0.01% | 676 |
|
|
2023
Q2 | $6.44K | Buy |
63
+41
| +186% | +$4.19K | ﹤0.01% | 807 |
|
|
2023
Q1 | $3.81K | Hold |
22
| – | – | ﹤0.01% | 906 |
|
|
2022
Q4 | $8.32K | Buy |
22
+1
| +5% | +$378 | ﹤0.01% | 675 |
|
|
2022
Q3 | $7K | Hold |
21
| – | – | ﹤0.01% | 732 |
|
|
2022
Q2 | $7K | Hold |
21
| – | – | ﹤0.01% | 713 |
|
|
2022
Q1 | $9K | Hold |
21
| – | – | ﹤0.01% | 677 |
|
|
2021
Q4 | $9K | Hold |
21
| – | – | ﹤0.01% | 690 |
|
|
2021
Q3 | $12K | Buy |
21
+20
| +2,000% | +$11.4K | ﹤0.01% | 624 |
|
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 937 |
|